178 related articles for article (PubMed ID: 23399737)
1. Spontaneous regression of colonic lymphoma following infliximab and azathioprine withdrawal in patients with Crohn's disease.
Flynn AD; Azar JM; Chiorean MV
Inflamm Bowel Dis; 2013 Apr; 19(5):E69-70. PubMed ID: 23399737
[No Abstract] [Full Text] [Related]
2. Predictors of infliximab failure after azathioprine withdrawal in Crohn's disease treated with combination therapy.
Oussalah A; Chevaux JB; Fay R; Sandborn WJ; Bigard MA; Peyrin-Biroulet L
Am J Gastroenterol; 2010 May; 105(5):1142-9. PubMed ID: 20389296
[TBL] [Abstract][Full Text] [Related]
3. Extra-intestinal Hodgkin's lymphoma in a Crohn's disease patient on long-term azathioprine and infliximab therapy.
Dahhan T; Al Kahtani K; Bakshi N; Abouzied ME; Helmy A
Trop Gastroenterol; 2010; 31(1):51-3. PubMed ID: 20860231
[No Abstract] [Full Text] [Related]
4. [Indications and results of infliximab in Crohn's disease].
Karoui S; Boubaker J; Filali A
Tunis Med; 2004 Dec; 82(12):1057-63. PubMed ID: 15822505
[TBL] [Abstract][Full Text] [Related]
5. Pneumocystis jiroveci (carinii) pneumonia after initiation of infliximab and azathioprine therapy in a patient with Crohn's disease.
Seddik M; Melliez H; Seguy D; Viget N; Cortot A; Colombel JF
Inflamm Bowel Dis; 2005 Jun; 11(6):618-20. PubMed ID: 15905713
[No Abstract] [Full Text] [Related]
6. Pneumocystis jiroveci (carinii) pneumonia following initiation of infliximab and azathioprine therapy in a patient with Crohn's disease.
Seddik M; Meliez H; Seguy D; Viget N; Cortot A; Colombel JF
Inflamm Bowel Dis; 2004 Jul; 10(4):436-7. PubMed ID: 15475754
[TBL] [Abstract][Full Text] [Related]
7. Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial.
Van Assche G; Magdelaine-Beuzelin C; D'Haens G; Baert F; Noman M; Vermeire S; Ternant D; Watier H; Paintaud G; Rutgeerts P
Gastroenterology; 2008 Jun; 134(7):1861-8. PubMed ID: 18440315
[TBL] [Abstract][Full Text] [Related]
8. Diffuse large B-cell lymphoma of the colon and rectum in a patient with colonic Crohn's disease treated with infliximab and azathioprine.
Sato K; Suga T; Hirayama A; Daikuhara S; Uehara T; Tanaka E
Clin J Gastroenterol; 2020 Feb; 13(1):1-5. PubMed ID: 31350718
[TBL] [Abstract][Full Text] [Related]
9. Drug interaction between infliximab and azathioprine in patients with Crohn's disease.
Roblin X; Serre-Debeauvais F; Phelip JM; Bessard G; Bonaz B
Aliment Pharmacol Ther; 2003 Nov; 18(9):917-25. PubMed ID: 14616155
[TBL] [Abstract][Full Text] [Related]
10. Infliximab-induced thrombocytopenia in an elderly patient with ileocolonic Crohn's disease.
Mocciaro F; Russo G; Di Mitri R; Marino A
Inflamm Bowel Dis; 2013; 19(4):E52-3. PubMed ID: 22535599
[No Abstract] [Full Text] [Related]
11. Remission maintained by monotherapy after biological + immunosuppressive combination for Crohn's disease in clinical practice.
Ampuero J; Rojas-Feria M; Castro-Fernández M; Millán-Lorenzo M; Guerrero-Jiménez P; Romero-Gómez M
J Gastroenterol Hepatol; 2016 Jan; 31(1):112-8. PubMed ID: 26173493
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous nevi pigmentosus during infliximab therapy in a patient with Crohn's disease: fallacy or coincidence?
Katsanos KH; Christodoulou DK; Zioga A; Tsianos EV
Inflamm Bowel Dis; 2003 Jul; 9(4):279. PubMed ID: 12902853
[No Abstract] [Full Text] [Related]
13. Effectiveness and tolerability of repeated treatment with infliximab in patients with Crohn's disease: a retrospective data analysis in Germany.
Witthöft T; Ludwig D
Int J Colorectal Dis; 2005 Jan; 20(1):18-23. PubMed ID: 15459773
[TBL] [Abstract][Full Text] [Related]
14. Plasmablastic lymphoma presenting as a paravertebral mass in a patient with Crohn's disease after immunosuppressive therapy.
Redmond M; Quinn J; Murphy P; Patchett S; Leader M
J Clin Pathol; 2007 Jan; 60(1):80-1. PubMed ID: 17213349
[TBL] [Abstract][Full Text] [Related]
15. [Systemic candidiasis and infliximab therapy].
Belda A; Hinojosa J; Serra B; García L; Merino C; Belda A; Molés JR
Gastroenterol Hepatol; 2004; 27(6):365-7. PubMed ID: 15207136
[TBL] [Abstract][Full Text] [Related]
16. Timing infliximab therapy in pediatric Crohn's disease.
Kirschner BS; Huo D
Gastroenterology; 2007 Mar; 132(3):1167-70. PubMed ID: 17383435
[No Abstract] [Full Text] [Related]
17. Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped.
Louis E; Mary JY; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Dupas JL; Pillant H; Picon L; Veyrac M; Flamant M; Savoye G; Jian R; Devos M; Porcher R; Paintaud G; Piver E; Colombel JF; Lemann M;
Gastroenterology; 2012 Jan; 142(1):63-70.e5; quiz e31. PubMed ID: 21945953
[TBL] [Abstract][Full Text] [Related]
18. Induction of pustular lesions during infliximab therapy for Crohn's disease.
Pérez-Pérez L; Caeiro JL; Fabeiro JM; Allegue F; Zulaica A
Acta Derm Venereol; 2008; 88(3):292-3. PubMed ID: 18480940
[No Abstract] [Full Text] [Related]
19. Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance.
Francis G; Duggan A
Gastroenterology; 2008 Dec; 135(6):2156-7. PubMed ID: 19013168
[No Abstract] [Full Text] [Related]
20. Infliximab, azathioprine, or combination therapy for Crohn's disease.
Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens G; Diamond RH; Broussard DL; Tang KL; van der Woude CJ; Rutgeerts P;
N Engl J Med; 2010 Apr; 362(15):1383-95. PubMed ID: 20393175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
